CDC Simplifies COVID-19 Vaccination Recommendations for Those 65+ and/or Immunocompromised

COVID-19 vaccines are still considered an effective way to ward off serious illness from COVID, especially for more vulnerable groups like the immunocompromised and those ages 65 and older. To protect these groups against current strains of the virus, the CDC now recommends two doses of the 2024-2025 COVID-19 vaccine (Moderna, Pfizer-BioTech or Novavax) to be received six months apart.

For those considered moderately or severely immunocompromised—defined by the CDC as anyone having a weakened immune system due to a medical condition or who is receiving medications or treatments that suppress your immune system—the CDC recommends you consult with your healthcare provider to determine if a third dose of the 2024-2025 COVID-19 vaccine or more are needed.

NOTE: The CDC recommends that everyone stay up to date with the COVID-19 vaccination schedule. Find the most recent COVID-19 vaccine recommendations for your age group at www.cdc.gov/covid/vaccines/stay-up-to-date.html.

For participants covered under the Health Plan, COVID vaccinations are covered at 100% under the Affordable Care Act’s preventive care benefits if administered by a network provider or network pharmacy. To schedule a COVID vaccination at your local CVS Caremark pharmacy, visit www.cvs.com.